AIM ImmunoTech Cash Flow Statement (2010-2026)

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Cash Flow Statement	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026	Jun2026
Operating Activities
Net Income (Quarter)	-5.07M	-7.45M	-3.34M	-4.86M	-6.76M	-5.63M	-4.50M	-5.66M	-8.36M	-14.14M	-8.31M	-6.33M	-4.71M	-5.99M	-3.81M	-4.94M	-2.63M	-3.23M	-3.22M	-7.13M
Depreciation and Depletion (Quarter)	0.16M	0.17M	0.01M	0.01M	0.01M	0.01M	0.01M	0.01M	0.01M	0.01M	0.01M	0.01M	0.01M	0.01M	0.01M	0.01M	0.01M	0.01M	0.01M	0.01M
Share-based Compensation (Quarter)	0.28M	-1.26M	0.24M	0.45M	0.28M	0.16M	0.13M	0.09M	0.04M	0.06M	0.08M	0.08M	0.05M	-0.10M	0.06M			-100.00
Gains from Investment Securities (Quarter)	-0.05M	-0.12M	-0.03M	-0.00M	-0.00M												-0.67M	0.94M	0.47M
Asset Writedowns and Impairment (Quarter)														0.00M	0.34M	0.28M	0.08M	0.44M
Cash from Operations (Quarter)	-3.46M	-5.75M	-2.76M	-2.31M	-4.97M	-6.07M	-3.68M	-2.16M	-5.67M	-9.76M	-4.82M	-3.01M	-3.11M	-3.96M	-2.36M	-1.53M	-5.08M	-1.99M	-2.72M	-4.59M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles (Quarter)											0.07M	0.20M	-0.04M		0.06M	0.12M	0.07M
Amortization of Deferred Charges (Quarter)											0.07M	0.20M	-0.04M	0.07M
Depreciation & Amortization (CF) (Quarter)	0.16M	0.17M	0.01M	0.01M	0.01M	0.01M	0.01M	0.01M	0.01M	0.01M	0.01M	0.01M	0.01M	0.01M	0.01M	0.01M	0.01M	0.01M	0.01M	0.01M
Change in Working Capital
Change in Receivables (Quarter)		-0.03M				1.68M				1.18M	-1.18M	0.00M		-0.00M
Change in Inventory (Quarter)
Change in Account Payables (Quarter)	-0.08M	-0.17M	0.18M	0.33M	0.24M	-0.58M	0.59M	1.19M	0.64M	3.65M	0.12M	-1.11M	0.81M	0.12M	0.56M	0.35M	-2.57M	-0.06M	-0.41M
Change in Accured Expenses (Quarter)	-0.01M	0.08M	-0.11M	0.17M	1.26M	-0.96M	-0.11M	-0.17M	1.19M	0.27M	-0.54M	-0.65M	0.39M	-0.40M	0.06M	-0.10M	0.29M	0.16M	0.03M	-1.39M
Other Working Capital Changes (Quarter)	0.01M	-1.57M	-0.01M	0.08M	0.00M	0.08M	0.18M	-0.14M	-0.23M	0.68M	0.06M	-0.07M	0.07M	-0.64M	-0.37M	0.36M	-0.02M	-0.70M	-0.05M	0.03M
Investing Activities
Capital Expenditures (Quarter)	0.01M	0.01M
Sales of Property, Plant and Equipment (Quarter)						3.60M	0.03M	0.01M
Change in Acquisitions & Divestments (Quarter)	-0.76M	21.44M	0.41M	8.31M	0.37M	1.00M	0.60M				0.05M	1.05M	0.49M	4.03M	1.04M	0.98M	0.30M		0.00M
Cash from Investing Activities (Quarter)	-0.37M	0.36M	-0.35M	7.72M	0.25M	3.36M	-0.08M	-0.20M	-0.34M	-0.21M	-0.16M	0.83M	0.33M	3.70M	0.90M	0.75M	0.30M	-0.10M	-0.04M	-0.11M
Financing Activities
Other financing activities (Quarter)																			2.16M	3.58M
Cash from Financing Activities (Quarter)	0.03M	0.12M			0.03M		0.10M	0.01M	0.23M	0.15M	2.83M	2.44M	0.14M	1.04M	0.66M	0.35M	6.65M	2.72M	5.59M	8.79M
Change in Capital Stock
Net Equity Issued and Repurchased (Quarter)	0.03M	0.12M			0.03M		0.10M	0.01M	0.23M	0.15M	0.33M	0.53M	1.26M	-0.21M	0.66M	0.10M	-0.40M	-0.11M	2.00M	0.54M
Additional items
Change in Cash (Quarter)	-3.79M	-5.26M	-3.10M	5.46M	-4.69M	-2.71M	-3.66M	-2.36M	-5.77M	-9.82M	-2.14M	0.26M	-2.64M	0.79M	-0.80M	-0.42M	1.87M	0.64M	2.83M	4.08M
Free Cash Flow (Quarter)	-3.46M	-5.75M	-2.76M	-2.31M	-4.97M	-6.07M	-3.68M	-2.16M	-5.67M	-9.76M	-4.82M	-3.01M	-3.11M	-3.96M	-2.36M	-1.53M	-5.08M	-1.99M	-2.72M	-4.59M
Net Cash Flow (Quarter)	-3.79M	-5.26M	-3.10M	5.41M	-4.69M	-2.71M	-3.66M	-2.36M	-5.77M	-9.82M	-2.14M	0.26M	-2.64M	0.79M	-0.80M	-0.42M	1.87M	0.64M	2.83M	4.08M

Research Tools

Datasets

Plans

Developers

AIM ImmunoTech AIM Cash Flow Statement (2010-2026)

Research Tools

Datasets

Plans

Developers

AIM ImmunoTech AIM Cash Flow Statement (2010-2026)

Create an account

Sign In

Reset Password